Clinical trials
Phase 1/2 Idiopathic Pulmonary Fibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arrowhead Pharmaceuticals | 1 |
| Federal Research Clinical Center of Federal Medical & Biological Agency, Russia | 1 |
| Galecto Biotech AB | 1 |
| Guangdong Raynovent Biotech Co., Ltd | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| Kasiak Research Pvt. Ltd. | 1 |
| National Jewish Health | 1 |
| Paul Szabolcs | 1 |
| Sanofi | 1 |
| Shanghai East Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Idiopathic Pulmonary Fibrosis | 13 |
| Anemia, Aplastic | 1 |
| Bone Marrow Failure Disorders | 1 |
| Emphysema | 1 |
| Idiopathic Interstitial Pneumonias | 1 |
| Lung Diseases, Interstitial | 1 |
| Pulmonary Disease, Chronic Obstructive | 1 |
| Pulmonary Fibrosis | 1 |
Trials
Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.